Souhaitez-vous accéder aux communiqués récents ?

ROUYN-NORANDA, QUÉBEC--(Marketwired - 12 nov. 2015) - ENTREPRISES MINIÈRES GLOBEX INC. (TSX:GMX)(FRANKFURT:G1M)(STUTTGART:G1M)(BERLIN:G1M)(MUNICH:G1M)(XETRA:G1M)(OTCQX:GLBXF)...

ROUYN-NORANDA, QUEBEC--(Marketwired - Nov. 12, 2015) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1M)(STUTTGART:G1M)(BERLIN:G1M)(MUNICH:G1M)(XETRA:G1M)(OTCQX:GLBXF) is pleased to...

Tumor-Checkpoint-Controller BAL101553 zeigt in Hirntumor-Modellen Hemmung der Selbsterneuerung und der invasiven Eigenschaften von Tumorstammzellen BAL101553-induzierter Verlust der...

Tumor check point controller BAL101553 demonstrates inhibitory activity on tumor stem cell self-renewal and invasion in models of brain cancer Loss of glioblastoma stem cell properties induced by...

Basel, 23. Oktober 2015 - Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass die Einstufung des Antimykotikums Isavuconazol als Orphan Drug für die Behandlung von invasiver Aspergillose...

Basel, Switzerland, October 23, 2015 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the orphan drug designation of the antifungal isavuconazole for the treatment of invasive...

VANCOUVER, British Columbia, Oct. 20, 2015 (GLOBE NEWSWIRE) -- MPH Ventures Corp. (TSX-V:MPS) (OTCBB:MPSFF) (Frankfurt:IJA2) (the "Company") is pleased to announce, further to its news releases of...

Basilea plant Gang an US-Kapitalmarkt Ziel des Emissionsangebots ist es, die Liquidität und Visibilität der Basilea-Aktie zu erhöhen und zusätzliche Analysten-Coverage zu erhalten Basilea...

Basilea seeks access to U.S. public equity market The offering is intended to: increase liquidity, visibility and coverage for Basilea shares facilitate Basilea's participation in...

Basilea's second anti-infective product approved in Europe, providing potential commercial synergy with Zevtera® (ceftobiprole) BASEL, Switzerland, Oct. 16, 2015 (GLOBE NEWSWIRE) -- Basilea...